INMED PHARMACEUTICALS INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
INMED PHARMACEUTICALS INC. (INM) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $1.52 million for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-06-30 was $190.38K.
- INMED PHARMACEUTICALS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-06-30 was -$754.03K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|
| 2026-06-30 | $190.38K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $1.52M S-4/A · filed 2026-09-09 | |
| 2026-03-31 | $1.33M S-4 · filed 2026-07-02 | ||
| 2025-06-30 | -$754.03K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | -$183.54K S-4/A · filed 2026-09-09 | |
| 2025-03-31 | $570.48K S-4 · filed 2026-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |